|
US2020222477A1
|
|
Method to Curtail the Progression of Non-Muscle Invasive Bladder Cancer To Muscle-Invasive Cancer
|
|
US2019292609A1
|
|
Gene Therapy Vector Contamination Assay
|
|
US2019275106A1
|
|
Anti-Angiogenic Gene Therapy Kit
|
|
EP3723780A1
|
|
Cdkn2a companion diagnostic for bladder cancer interferon therapy
|
|
CN110088264A
|
|
Attached cell culture substrate sampler
|
|
CA3021045A1
|
|
Large scale pei-mediated plasmid transfection
|
|
US2020129436A1
|
|
Viral Vector Stabilization
|
|
CN109071594A
|
|
With constant flow pump/pipe-line system fixed-bed bioreactor
|
|
CA3089875A1
|
|
Improved interferon therapy
|
|
US2019338307A1
|
|
Viral Vector Assay and Vector
|
|
US2017051309A1
|
|
Seeding An Adherent Cell Bioreactor With Non-Adherent Cells Increases Seeding Density Limit And Reduces Required Expansion Time
|
